Breakthrough Discovery Paves Way for Innovative Colorectal Cancer Therapies
Fusobacterium nucleatum, an anaerobic bacterium increasingly recognized for its role in colorectal cancer (CRC), has taken center stage in groundbreaking research that elucidates how this...